KETROUP-DT contains Ketorolac Tromethamine 10 mg, a potent NSAID analgesic formulated for short-term management of moderate to severe acute pain. A focused PCD Pharma Analgesic portfolio product.
Short-term management of moderate to severe acute pain.
No, it is intended for short-term use only.
Use at the lowest effective dose for the shortest prescribed duration. Avoid combining with other NSAIDs. Inform the doctor about ulcers, kidney disease, anticoagulant use or bleeding disorders.
Gastric irritation, nausea, indigestion, abdominal pain, dizziness and headache may occur; gastrointestinal bleeding and kidney injury are important risks.
KETROUP-DT: Ketorolac inhibits prostaglandin synthesis, producing potent analgesic and anti-inflammatory effects through peripheral cyclooxygenase inhibition.
